Glimepiride & Metformin Hydrochloride (Sustained Release) Tablets combine two widely trusted antidiabetic medicines Glimepiride 1 mg and Metformin Hydrochloride 500 mg (SR) — formulated for effective control of Type 2 Diabetes Mellitus. This synergistic combination helps lower blood glucose levels by increasing insulin secretion and reducing hepatic glucose production. Manufactured by Globus Labs, the sustained-release formulation ensures steady glycemic management throughout the day.
Glimepiride (1 mg):
A sulfonylurea-class antidiabetic agent that stimulates pancreatic β-cells to release insulin, helping reduce elevated blood sugar levels effectively.
Metformin Hydrochloride (500 mg, SR):
A biguanide that lowers hepatic glucose production, slows sugar absorption from the intestine, and enhances insulin sensitivity. The sustained-release technology provides longer-lasting glycemic control with improved gastrointestinal comfort.
Take Glimepiride & Metformin Hydrochloride SR Tablets once daily with food or as prescribed by your healthcare professional. Swallow the tablet whole with water. Do not crush or chew. Maintain a healthy diet and regular physical activity for optimal blood sugar regulation.
Mild effects may include stomach discomfort, nausea, headache, dizziness, or low blood sugar (hypoglycemia). These effects are usually temporary. Seek medical advice if symptoms persist or worsen.
Globus Labs brings you WHO-GMP–certified, high-quality Glimepiride 1 mg + Metformin Hydrochloride 500 mg sourced from reputed pharmaceutical manufacturers. Glymtop-M1 is formulated to deliver safe, potent, and clinically trusted support.
Whether you’re seeking a franchise opportunity, exploring wholesale distribution, or evaluating Globus Labs for international trade, we’re here to help you build a strong, profitable partnership. Let’s discuss how we can grow together and create meaningful value for your business.